Vor Biopharma, Inc. (VOR)
16.59
-0.68
(-3.94%)
USD |
NASDAQ |
Jan 23, 16:00
16.64
+0.05
(+0.30%)
After-Hours: 20:00
Vor Biopharma Shareholders Equity (Quarterly): -2.225B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Outset Medical, Inc. | 142.36M |
| iBio, Inc. | 56.04M |
| Decoy Therapeutics, Inc. | 4.248M |
| Recursion Pharmaceuticals, Inc. | 1.047B |
| Senti Biosciences, Inc. | 8.121M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 176.24M |
| Total Liabilities (Quarterly) | 2.402B |
| Debt to Equity Ratio | -0.0014 |
| Current Ratio | 9.156 |
| Net Debt Paydown Yield | 1.85% |